Production Losses Due to Mortality Associated with Modifiable Health Risk Factors in Poland

Overview

Journal Eur J Health Econ

Specialty Health Services

Date 2021 Jul 8

PMID 34236544

Citations 3

Authors

Blazej Lyszczarz

Karolina Sowa

Affiliations

Soon will be listed here.

Abstract

Background: Epidemiological burden of modifiable mortality risk factors is recognized in literature; however, less is known on the economic losses due to a range of such risks.

Aim: To estimate production losses (indirect cost) of mortality associated with risk factors as classified in Global Burden of Disease 2019 Study in Poland in years 2000, 2010, and 2017.

Methods: We relied on the human capital method and societal perspective and used sex-, age-, region-, and risk-specific data on mortality due to modifiable risk factors and a set of socio-economic measures.

Results: The production losses due to mortality attributable to all investigated risk factors accounted for 19.6-21.0 billion PLN (Polish zloty; 2017 exchange rate: 1€ = 4.26 PLN) and 1.44-2.45% of gross domestic product, depending on year. Behavioural factors were the most important contributor to overall burden (16.7-18.2 billion PLN), followed by metabolic factors (6.8-7.6 billion PLN) and environmental and occupational factors (3.0-3.5 billion PLN). Of disaggregated risks, alcohol and tobacco, high systolic blood pressure, and dietary risks proved to lead to the highest losses. Cost per death was greatest for child and maternal malnutrition, followed by intimate partner violence and childhood sexual abuse and bullying. Moreover, a notable regional variation of indirect cost was identified with losses ranging from 1.21 to 1.81% of regional gross domestic product in 2017.

Conclusion: Our findings provide economically hierarchised list of modifiable risk factors and they contribute to inform policy-makers in prioritizing programmes to improve health.

Citing Articles

Economic costs attributable to modifiable risk factors: an analysis of 24 million urban residents in China.

Xiong X, Huo Z, Zhou Y, Bishai D, Grepin K, Clarke P BMC Med. 2024; 22(1):549.

PMID: 39574122 PMC: 11580671. DOI: 10.1186/s12916-024-03772-7.

Productivity losses from short-term work absence due to neoplasms in Poland.

Lyszczarz B Sci Rep. 2024; 14(1):3289.

PMID: 38332168 PMC: 10853257. DOI: 10.1038/s41598-024-53878-4.

The societal cost of modifiable risk factors in Singapore.

Tan V, Lim J, Akksilp K, Chow W, Ma S, Chen C BMC Public Health. 2023; 23(1):1285.

PMID: 37403019 PMC: 10318651. DOI: 10.1186/s12889-023-16198-2.

References

Goryakin Y, Thiebaut S, Cortaredona S, Lerouge M, Cecchini M, Feigl A . Assessing the future medical cost burden for the European health systems under alternative exposure-to-risks scenarios. PLoS One. 2020; 15(9):e0238565. PMC: 7485835. DOI: 10.1371/journal.pone.0238565. View

Jonsson B . Ten arguments for a societal perspective in the economic evaluation of medical innovations. Eur J Health Econ. 2009; 10(4):357-9. DOI: 10.1007/s10198-009-0173-2. View

Kalinowski P . Excess male mortality at the productive age in Poland at the end of the 20th century. Ann Univ Mariae Curie Sklodowska Med. 2002; 56:177-82. View

Lyszczarz B . Production Losses Associated with Alcohol-Attributable Mortality in the European Union. Int J Environ Res Public Health. 2019; 16(19). PMC: 6801817. DOI: 10.3390/ijerph16193536. View

Rivera B, Casal B, Currais L . Crisis, suicide and labour productivity losses in Spain. Eur J Health Econ. 2016; 18(1):83-96. DOI: 10.1007/s10198-015-0760-3. View

Cadilhac D, Magnus A, Sheppard L, Cumming T, Pearce D, Carter R . The societal benefits of reducing six behavioural risk factors: an economic modelling study from Australia. BMC Public Health. 2011; 11:483. PMC: 3146859. DOI: 10.1186/1471-2458-11-483. View

Pike J, Grosse S . Friction Cost Estimates of Productivity Costs in Cost-of-Illness Studies in Comparison with Human Capital Estimates: A Review. Appl Health Econ Health Policy. 2018; 16(6):765-778. PMC: 6467569. DOI: 10.1007/s40258-018-0416-4. View

Hanly P, Soerjomataram I, Sharp L . Measuring the societal burden of cancer: the cost of lost productivity due to premature cancer-related mortality in Europe. Int J Cancer. 2014; 136(4):E136-45. DOI: 10.1002/ijc.29105. View

Lyszczarz B . Production losses associated with premature mortality in 28 European Union countries. J Glob Health. 2019; 9(2):020418. PMC: 6790234. DOI: 10.7189/jogh.09.020418. View

10.

Oliva J, Lobo F, Lopez-Bastida J, Zozaya N, Romay R . Indirect costs of cervical and breast cancers in Spain. Eur J Health Econ. 2005; 6(4):309-13. DOI: 10.1007/s10198-005-0303-4. View

11.

Zhang W, Bansback N, Anis A . Measuring and valuing productivity loss due to poor health: A critical review. Soc Sci Med. 2010; 72(2):185-92. DOI: 10.1016/j.socscimed.2010.10.026. View

12.

Neumann P . Costing and perspective in published cost-effectiveness analysis. Med Care. 2009; 47(7 Suppl 1):S28-32. DOI: 10.1097/MLR.0b013e31819bc09d. View

13.

Pikala M, Maniecka-Bryla I . Fifteen-year mortality trends in Poland analysed with the use of standard expected years of life lost, 2000-2014. Sci Rep. 2017; 7(1):8730. PMC: 5562698. DOI: 10.1038/s41598-017-09441-5. View

14.

Krueger H, Williams D, Ready A, Trenaman L, Turner D . Improved estimation of the health and economic burden of chronic disease risk factors in Manitoba. Chronic Dis Inj Can. 2013; 33(4):236-46. View

15.

Diaz-Jimenez D, Castaneda-Orjuela C, Castillo-Rodriguez L, De la Hoz-Restrepo F . Economic Costs Analysis of the Avoidable Mortality in Colombia 1998-2011. Value Health Reg Issues. 2018; 8:129-135. DOI: 10.1016/j.vhri.2015.08.007. View

16.

Verhaeghe N, Lievens D, Annemans L, Vander Laenen F, Putman K . The health-related social costs of alcohol in Belgium. BMC Public Health. 2017; 17(1):958. PMC: 5732489. DOI: 10.1186/s12889-017-4974-4. View

17.

Catala-Lopez F, Garcia-Altes A, Alvarez-Martin E, Genova-Maleras R, Morant-Ginestar C, Parada A . Burden of disease and economic evaluation of healthcare interventions: are we investigating what really matters?. BMC Health Serv Res. 2011; 11:75. PMC: 3097252. DOI: 10.1186/1472-6963-11-75. View

18.

. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258):1223-1249. PMC: 7566194. DOI: 10.1016/S0140-6736(20)30752-2. View

19.

Acs P, Kovacs A, Paar D, Hoffbauer M, Szabo P, Szabo T . Comparative analysis of the economic burdens of physical inactivity in Hungary between 2005 and 2017. BMC Public Health. 2020; 20(Suppl 1):1174. PMC: 7429901. DOI: 10.1186/s12889-020-08478-y. View

20.

Neumann P, Thorat T, Zhong Y, Anderson J, Farquhar M, Salem M . A Systematic Review of Cost-Effectiveness Studies Reporting Cost-per-DALY Averted. PLoS One. 2016; 11(12):e0168512. PMC: 5179084. DOI: 10.1371/journal.pone.0168512. View